However, before vaccines, especially 100+ years ago, the disease was a real killer. It still is in Africa, despite vaccines. Why is it almost never contracted in the first world now.?

The short version: tetanus is rare in the first world because of sanitation and wound care, not just the vaccine. The vaccine's role is smaller than you have been told.

Tetanus is caused by a bacterium that lives in soil and manure. It does not spread from person to person. You need a wound contaminated with spores, and the wound needs to be deep enough to create a low-oxygen environment for the spores to germinate. In high-income countries, paved surfaces, modern plumbing, and widespread use of antiseptics and antibiotics mean far fewer opportunities for the bacterium to enter a wound and survive. A 1988 study in Kenya found that home delivery carried a tetanus death rate of 14.1 per 1,000 live births, while delivery in a health institution carried 4.3 per 1,000 [6]. That is a threefold difference from hygiene alone, before any vaccine.

The vaccine does reduce risk. A systematic review found that two doses of tetanus toxoid in pregnant women reduced neonatal tetanus mortality by about 94% [7]. But that number comes from settings where the background risk is high, hygiene is poor, and the disease is common. In a country where the background risk is already very low, the absolute benefit of the vaccine is much smaller. The same review notes that the quality of the evidence was moderate, drawn from one randomized trial in Colombia and one cohort in India [7].

The evidence also shows that natural immunity is real. A 1993 Italian study found that about 95% of young adults had protective antibodies against tetanus without necessarily being vaccinated [2]. A study of Swiss adults with inflammatory bowel disease found high seroprotection rates despite poor vaccination coverage [1]. Human colostrum and milk contain secretory IgA that neutralizes tetanus toxin, giving breastfed infants passive protection [3]. The body can mount a primary immune response to small doses of toxin from minor wounds that never become infected.

The vaccine is not harmless. A 1988 mouse study found that tetanus toxoid caused structural chromosome aberrations in spermatocytes, and the effect was stronger when combined with another vaccine [3]. A 2026 VAERS analysis of children under 7 found 143 positive safety signals after DTaP, including a signal for sudden infant death syndrome with 67.8% of cases occurring within 6 days of vaccination [5]. The authors treat this as temporal association, not causation, but the signal exists. A population-based study found no increased risk of Guillain-Barré syndrome after tetanus-toxoid vaccines, but the IOM concluded the evidence favored acceptance of a causal relationship based on two rechallenge-positive case reports [4].

The disease is rare in the first world because of sanitation, wound care, and antibiotics. The vaccine adds a layer of protection on top of that, but the absolute benefit is small for most healthy adults. The burden of proof is on the people asking you to accept an injection, and that burden has not been met for routine tetanus boosters in healthy adults in high-income countries.

My call: the evidence does not support routine tetanus vaccination for most healthy adults in North America. The disease is rare, natural immunity is common, and the vaccine's benefit is overstated for this population. Confidence: moderate.